View monthly record counts
| Month | Records |
|---|---|
| 1 | |
| 1 |
Local name: AIO A.D
Data updated:
| Month | Records |
|---|---|
| 1 | |
| 1 |
| # | Country / Region | Records |
|---|---|---|
| 1 | Ireland | 1 |
| 2 | United States | 1 |
| # | HS Code | Description (CN) | Description (EN) | Records |
|---|---|---|---|---|
| 1 | 300215 | 免疫制品,已配定剂量或制成零售包装 | Immunological products, put up in measured doses or in forms or packings for retail sale | 2 |
| # | Partner Name | Country / Region | Records |
|---|---|---|---|
| 1 | MULTICARE PHARMACEUTICALS | IRELAND | 2 |
| Date | Nov 25, 2025 | Bill No. | 72486543586 | ||
|---|---|---|---|---|---|
| Supplier Information | Company Name | MULTICARE PHARMACEUTICALS | Buyer Information | Company Name | AIO |
| Address | NW 87TH PLACE, 2402, DORAL | Address | QS 3 EPCT LOTES 3, 5, 7 E 9, SN, AREAL (AGUAS CLARAS, CEP: 71953000 - BRASILIA, DF - 61 33644694 | ||
| Registration No. | — | Registration No. | 11 859 927 0001 06 | ||
| Phone | — | Phone | — | ||
| — | — | ||||
| Product Information | HS Code | 30021590 | HS Description | 免疫制品,已配定剂量或制成零售包装Immunological products, put up in measured doses or in forms or packings for retail sale | |
| Product Description | ULTOMIRIS - SOLUÇÃO PARA DILUIÇÃO PARA INFUSÃO DE 300 MG/3 ML (100 MG/ML). EMBALAGEM COM 1 FRASCO-AMPOLA CONTENDO 3 ML DA SOLUÇÃO PARA APLICAÇÃO INTRAVENOSA. PRINCIPIO ATIVO: RAVULIZUMABE. TEMPERATURA: +2° E +8°. REGISTRO ANVISA: 1161803010021. VALIDADE: 09/2029. PRODUTO NOVO COM VALIDADE DE 18 MESES. NÚMERO DE LOTE: 1005494. DATA DE FABRICAÇÃO: 14/05/2025. | Brand | — | ||
| Quantity & Price | Amount | 49,001.91 | Weight | 0.35 kg | |
| Quantity | 11 FRASCOS | TEU | — | ||
| Shipment Information | Origin Country | IRELAND | Destination Country | BRAZIL | |
| Port of Loading | — | Destination Port | AEROPORTO INTERNACIONAL DE SAO PAULO GUARULHOS | ||
| Loading Place | — | Transport Mode | AIR | ||
| Transaction Mode | CIP | Carrier | — | ||
| Vessel Name | — | Voyage | — | ||
| Container No. | — | Shipping Country | — | ||